Aromatase expression and outcomes in the P024 neoadjuvant endocrine therapy trial
Aromatase expression and outcomes in the P024 neoadjuvant endocrine therapy trial
About this item
Full title
Author / Creator
Publisher
Boston: Springer US
Journal title
Language
English
Formats
Publication information
Publisher
Boston: Springer US
Subjects
More information
Scope and Contents
Contents
Background
Expression of aromatase by malignant breast epithelial cells and/or the surrounding stroma implies local estrogen production that could influence the outcome of endocrine therapy for breast cancer.
Methods
A validated immunohistochemical assay for aromatase was applied to samples from the P024 neoadjuvant endocrine therapy trial...
Alternative Titles
Full title
Aromatase expression and outcomes in the P024 neoadjuvant endocrine therapy trial
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2696016
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2696016
Other Identifiers
ISSN
0167-6806
E-ISSN
1573-7217
DOI
10.1007/s10549-008-0161-8
